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Abstract 
Background: Identifying the risk factors for diabetes mellitus related foot ulceration would save more limbs from 
amputation. This report focuses on the determining the burden of peripheral arterial disease and neuropathy in per-
sons with diabetes mellitus (DM).
Methods: This is a descriptive study carried out in the Diabetic Clinic of the Lagos State University Teaching Hospital 
in patients with DM who had no past/present history of foot ulceration. Biothesiometry was employed and ankle 
brachial pressure indices were measured to evaluate for neuropathy and peripheral arterial disease (PAD) respectively.
Results: A total of 225 persons living with DM who met inclusion criteria were recruited consecutively over a 
3 months period. Age range was 28–87 years with the mean [61.4 (10.8)] and median (63) years respectively. Patients 
symptomatic for neuropathy and PAD were 37 and 40 % respectively of the study population. An older age of 
>60 years and poor glycaemic control were potential predictors of neuropathy. Neuropathy and PAD occurred com-
monly in the seventh decade of life.
Conclusion: Given the fairly high proportions of neuropathy and PAD in our patients with DM, we recommend that 
they be routinely examined in persons with DM.
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Background
Peripheral arterial disease, a pointer to the presence of 
atherosclerosis is oft reported in diabetes mellitus (DM). 
Potential sequelae of this finding in DM are diverse rang-
ing from cardiovascular morbidity, the development 
of foot ulceration, increased risk for amputations and 
depending on severity, may result in death from any of 
the aforestated complications of DM. Neuropathy is a 
commonly documented complication of DM which may 
be asymptomatic but may lead to reduced quality of life 
in people who have painful neuropathy. Neuropathy is a 
well recognised risk factor of foot ulcers in persons with 
DM.
In order to reduce the burden of cardiovascular and 
foot complications of DM it is imperative to screen per-
sons with DM for these entities. There are a variety of 
screening techniques which are currently in use and 
these include the evaluation of vibration perception 
threshold (VPT) using the biothesiometer and documen-
tation of ABI to detect PAD [1]. In this Report, biothesi-
ometry which has been shown to have good correlation 
scores with tuning fork, monofilament and ankle reflex 
was employed for the purposes of quantifying vibratory 
sense.
Diabetic peripheral neuropathy which is documented 
to be present in 60  % of diabetic persons confers a 
great risk of foot ulceration; microvascular disease and 
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suboptimal glycemic control are also contributory. 
The prevalence of neuropathy was 76 % PAD was 6.3 % 
in patients without a prior history of foot ulceration as 
earlier reported in 2005 by Ogbera et al. [2]. The results 
of the Diabcare Report published in 2008, showed that 
peripheral neuropathy was documented in 59.2 % of per-
sons with DM in Nigeria [3]. When compared to the 33 % 
by Kinnear in 1963 [4] and 48 % by Osuntokun et al. in 
1971 [5], it is evident that peripheral neuropathy is on the 
increase in Nigeria.
People living with DM are at high risk for PAD which 
unfortunately is often associated with poor prognosis of 
foot ulceration. The determination of PAD using clinical 
symptoms is unreliable and the presence of neuropathy 
may be contributory to this scenario. Given the incon-
sistencies associated with the symptoms of PAD, the 
measurement of ankle-brachial pressure index (ABI) is an 
objective relatively simple, non-invasive and inexpensive 
technique employed in the evaluation of PAD. ABI test 
is widely used in the hospital setting not only to screen 
asymptomatic patients but also to diagnose patients with 
clinical symptom of PAD. In a Nigerian report on mid-
dle and elderly patients with DM, the prevalence rate of 
PAD was found to be 53 % [6]. Reports on PAD and neu-
ropathy from Nigeria have hardly assessed these entities 
objectively. Currently, health care providers in Nigeria 
are better equipped to detect neuropathy and PAD in a 
more objective manner than in the past two decades.
This study was done to document the burden of PAD 
and neuropathy in persons with DM.
Methods
This is a descriptive Study carried out at the Diabetes 
Clinic of the Lagos State University Teaching Hospi-
tal (LASUTH), Ikeja, Nigeria. This is a 750 bed hospital 
upgraded in 2001 from a General Hospital to a teaching 
hospital. It is located in the capital of Lagos State with 
highly subsidized health care costs as a result of govern-
mental policy.
Consenting patients were recruited consecutively 
over a 3-month period. All persons living with DM aged 
more than 20 years and who had no past histories of foot 
ulceration, were recruited into the study. Ethical approval 
was obtained from the Lagos State University Teaching 
Hospital.
Demography validated interviewer administered ques-
tionnaires were used to obtain histories pertaining to 
clinical characteristics of DM status and complications of 
neuropathy and PAD, smoking, alcohol and co-morbid-
ities such as hypertension. Long duration of DM means 
>10 years and older age referred to >60 years.
The anthropometric indices measured included waist 
circumference, height and body weight, and the body 
mass index (BMI) in weight/height2 (kg/m2). Waist cir-
cumference was determined by applying a tape measure 
to the midpoint between the inferior margin of the last 
rib and the crest of the ilium. The blood pressure was 
measured both in supine and upright positions.
A biothesiometer was used to determine semi quanti-
tatively vibration perception thresholds in a standardized 
manner by a single observer. The biothesiometer probe, 
which vibrates at an amplitude proportional to the square 
of the applied voltage, was applied perpendicularly to the 
test site with a constant and firm pressure. Subjects were 
initially familiarized with the sensation by holding the 
probe against the distal palmar surface of hand. VPT was 
then measured at the distal plantar surface of great toe of 
both the legs. The voltage was slowly increased at the rate 
of 1 mV/sec and the VPT value was defined as the voltage 
level when the subject indicated that he or she first felt 
the vibration sense.
DM Neuropathy referred to a vibration perception 
threshold values of more than 15 mV with or without the 
presence of neuropathic symptoms [7].
A hand held Doppler equipment with a frequency of 
12  MHz was used to document the ABI. The ABI was 
performed by measuring the systolic blood pressure from 
both brachial arteries and from both the dorsalis pedis 
and posterior tibial arteries after the patient has been at 
rest in the supine position for 10 min. We used a stand-
ard blood pressure cuff at the ankle. We began recording 
the pressures with the right arm, then the right leg, then 
the left leg, and finally the left arm.
The higher systolic blood pressure value was used as 
the numerator of the ABI in each limb. (An ABI of >1.30 
denoted incompressibility of the vessels and persons with 
such readings were excluded from the analyses). The 
diagnostic criteria for PAD based on the ABI were inter-
preted as follows:
Normal if 0.91–1.30, Mild obstruction if 0.70–0.90, 
Moderate obstruction if 0.40–0.69, Severe obstruction if 
<0.40, Poorly compressible if >1.30 [8].
HbA1c was assayed using a fully automated Boronate 
Affinity assay for the determination of the percentage of 
hemoglobin A1C (HbA1c %) in whole blood. Poor gly-
caemic control consisted of glycosylated hemoglobin 
(Hba1c) levels of ≥7 % [9].
Hypertension was said to be present in persons known 
to have a history of elevated blood.
Fasting blood samples were taken for the determination 
of four parameters of the lipid profile viz total cholesterol 
(TCHOL), high density lipoprotein cholesterol (HDL-C), 
and triglyceride (TG). Total cholesterol assay was done 
using a modified method of Liebermann-Burchard, HDL-
cholesterol by precipitation method and TG was esti-
mated using a kit employing enzymatic hydrolysis of TG 
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with lipases [10]. LDL-C was calculated using the Fried-
wald’s formula [10] LDL = (TCHOL − HDL-C) − TG/5 
when the values of TG were less than 400 mg %. Abnor-
mal lipid profile consisted of the following abnormalities 
either singly or in combination; triglyceride (TG) levels 
≥150  mg  %, high density lipoprotein cholesterol (HDL-
C) (for men ≤40 mg % and women ≤50 mg %), low den-
sity lipoprotein cholesterol (LDL-C) ≥100 mg % [10].
Statistical analyses were performed with SPSS ver-
sion 15. A multiple regression analysis with PAD as the 
dependent variable in conjunction with multiple inde-
pendent variables was used to evaluate for possible pre-
dictors of PAD. Independent sample Student’s t test was 
used to compare quantitative data. χ2 was used to test 




A total of 225 persons living with DM met the inclusion 
criteria. The age range was 28–87  years with the mean 
and median ages of the as 61.4 (10.8) and 63 years respec-
tively. There were 163 (68 %) females giving a M: F ratio 
of 1:2.6. The mean age of the males was greater than that 
of females and the difference was statistically significant 
(63.6 vs 60.4, p = 0.03).
Other clinical parameters are shown in Table 1.
Risk factors for DMFS
Neuropathy: Neuropathy was detected in 120 (56  %) of 
the study population. The proportions of females and 
males with neuropathy were comparable (M, 57 vs 56 % F, 
p = 0.9). Persons with neuropathy were older than those 
without neuropathy and this difference was statistically 
significant (63.9 (9) vs 58.2 (11) years, p = 0.0001). Posi-
tive symptoms of neuropathy ranging from burning noc-
turnal pain, pin and needle sensation were noted in 68 
patients and negative symptoms of numbness was docu-
mented in 16 patients. Poor long term glycaemic control 
and being elderly as shown in Table 2 were some factors 
that were found to be predictive for the occurrence of 
peripheral neuropathy. More than half—47 (52 %) of the 
people with DM who had neuropathy also had PAD. A 
comparison of some clinical parameters between patients 
with neuropathy and those without neuropathy showed 
that these indices were comparable in both groups; BMI 
(27.5 vs 27.8, p = 0.6), waist circumference indices (93.1 
vs 92.1, p  =  0.6), glycosylated haemoglobin (7.7 vs 7.7 
p = 0.9) and duration of DM (9.7 vs 8.6, p = 0.8).
Peripheral arterial disease
The total number of persons with PAD was 90 (40 %). The 
proportions of females and males PAD were comparable 
(M, 43 vs 39 %, p = 0.9). The mean age of persons with 
PAD and those without PAD was comparable. The results 
of comparisons made for some clinical and biochemi-
cal parameters between persons with PAD and persons 
without PAD is shown in Table 3.
DM associated neuropathy and peripheral arterial dis-
ease were prominent in the seventh decade of life. These 
results are shown in Fig. 1.
Dyslipidaemia
The proportions of the Study population with elevated 
total cholesterol, LDL-C, TG and low HDL levels were 99 
Table 1 Clinical characteristics of  the DM patients evalu-
ated for risk factors of foot ulceration
Parameter Mean (SD) Range
Age (years) 61.4 (10.8) 28–87
Duration of DM (years) 9.2 (7.6) 8–44
Body mass index (kg/m2) 27.6 (4.6) 17.5–42.5
Waist circumference (cm) 92.8 (12) 31–120
Haemoglobin (HbA1c) (%) 7.7 (2.1) 5–14
Table 2 Predictors of  peripheral neuropathy in  patients 
with diabetes mellitus
Variables OR 95 % confidence  
interval
p value
Age >60 years 2.6 1.4–4.8 0.02
Elevated HbA1c 2.0 1.1–3.80 0.002
Low HDL-C 2.1 0.4–8.3 0.3
Male sex 1.54 0.78–3 0.2
Elevated LDL-C 1.49 0.6–3.3 0.3
Duration of DM >10 years 1.29 0.7–2.6 0.4
Elevated TCHOL 1.1 0.4–2.5 0.8
Elevated TG 0.87 0.4–1.8 0.7
Overweight/obese 0.86 0.45–1.66 0.8
History of hypertension 0.72 0.36–0.72 0.3
PAD 0.73 0.42–1.3 0.3
Table 3 Comparison of  clinical parameters between  sub-
jects with PAD and those without PAD





Age (years) 61.2 (10.9) 61.5 (10.6) 0.8
Body mass Index (kg/m2) 27.8 (4.6) 27.5 (4.6) 0.8
HbA1c (%) 7.9 (2.2) 7.5 (1.8) 0.1
Duration of DM (years) 9.5 (7.7) 8.9 (7.6) 0.5
Waist circumference (cm) 93 (12.7) 92.5 (11.2) 0.3
Page 4 of 6Ogbera et al. BMC Res Notes  (2015) 8:533 
(44 %), 44 (20 %), 129 (57 %) and 66 (29 %) respectively. A 
comparison of the distribution of abnormal lipid param-
eters between DM patients with PAD and DM patients 
with neuropathy is shown in Fig. 2.
Discussion
There is a growing awareness amongst healthcare pro-
fessionals on the importance of early detection of risk 
factors for diabetes mellitus foot ulceration especially 
because this complication of DM has been associated 
with a high disease morbidity and mortality in resource 
poor countries.
In this report, neuropathy was a commonly docu-
mented entity and painful neuropathy its prominent 
symptom was noted in about half of the patients studied. 
Impaired vibration sense is an early sign of neuropathy, 
hence its assessment is an important element of the neu-
rological examination of the patient with diabetes [11]. 
We screened for neuropathy by means of biothesiometer, 
a recognised method of testing for vibration sensation. In 
a Study that compared the efficacy of the use of a bioth-
esiometer with that of the tuning fork the biothesiometer 
was found not only to have comparable efficacy to the 
tuning fork but was more useful in large outpatient clin-
ics [11]. In a Nigerian Study that reported the presence 
of neuropathy in persons with DM, the results showed 
that Bio-thesiometry detected neuropathy in 47.8  % of 
those with duration of DM <5 years and 100.0 % in those 
with duration of DM >15 years [12]. In our Report, neu-
ropathy was diagnosed more in older persons with an 
odds ratio (OR) of 2.6 for above 60  years (nearly three 
higher risk). Although an association between ageing 
and the occurrence of neuropathy has been attested to 
in many pertinent studies [13–15] it is instructive to note 
that neuropathy may occur in any age group as we have 
shown in our findings. Other clinical parameters such 
as duration of DM, glycaemic control, lipid parameters 
did not differ between persons with DM neuropathy and 
those without neuropathy.
A possible relation between glycaemic control and DM 
complications has being pointed out by findings from 
the UK Prospective Diabetes Study (UKPDS) [16] and 
not surprisingly our results showed that poor glycaemic 
control, a readily modifiable risk factor is a possible pre-
dictor of DM neuropathy. The prevalence of neuropathy 
has been reported in a Canadian Study to increase with 
increasing glucose [17]. The potential role of hypergly-
caemia in the pathogenesis of DM neuropathy has been 
explained by the polyol pathway theory and the glyco-
sylation end product pathway [18]. This is because glu-
cose uptake in peripheral nerves is not dependent on 
insulin and, high blood glucose levels in diabetes thus 
leads to high nerve glucose concentrations and this 
stimulates the polyol pathway [18]. Whilst some studies 
report duration of DM to be associated with DM related 
neuropathy, we found no such associations. This scenario 
may be explained partly by the fact that DMFS presents 
in 25 % as the initial manifestation of DM in our environ-
ment [19].
There is a dearth of Reports on detection on PAD using 
ABI from Africa. In a recent study from Uganda [20], the 
author noted that PAD was present in 39  % of persons 
with DM albeit with a male preponderance. These results 
are comparable to those of this Study. Our documented 
prevalence rate of PAD at 40 % is fairly high coming from 
Africa compared to earlier reported prevalence rang-
ing from 1.7 to 28  % [21]. The results from the Report 
by Oyelade [6] demonstrates an upward rise of PAD in 
Nigerians as compared to data obtained some few dec-
ades back. Peripheral arterial disease is unfortunately 
often asymptomatic and remains underdiagnosed in the 
majority of persons with DM [22]. Given the limitations 
of relying on the clinical history or physical examination, 
Series 1: DM patients with peripheral neuropathy





















Fig. 1 Distribution of neuropathy and peripheral arterial disease by 
age decades
Series 1-DM patients with abnormal lipid parameters
Series 2: DM patients with neuropathy and abnormal lipid parameters





















Fig. 2 Distribution of abnormal lipid parameters in persons with DM
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an additional noninvasive test, ABI, is widely adopted for 
confirmation of a clinical diagnosis of peripheral arterial 
disease and its quantification. The ABI is a measure of the 
blood pressure in the arteries supplying legs relative to 
central, aortic pressure (approximated by measuring the 
blood pressure in the arm).
Barring the limitations of occasional high ABI indices 
that may be suggestive of incompressibility of the vessels, 
calculating the ABI for screening purposes is of benefit in 
detecting PAD even in the absence of foot ulcers. How-
ever it is imperative to note that the handheld Dopplers 
equipment does not give waveform pattern as and such, 
may fail to detect the PAD when Monckebergs sclerosis 
is present. We excluded persons with high ABI because 
of the potential of misleadingly high figures in detected 
PAD.. Hitherto, apart for research purposes, screening 
for PAD is not carried out routinely for persons living 
with DM in the hospital setting in hospitals in Lagos. Of 
interest also are our findings of comparable clinical and 
biochemical parameters between patients with PAD and 
patients without PAD. In this Report, PAD, was diag-
nosed albeit in a few persons even in persons who were 
aged less than 40 years. Hypertension and dyslipidaemia, 
though of fairly high prevalence rate, their role in the 
possible development of PAD and neuropathy could not 
be ascertained in this report.
Limitations of the study
We did not document waveform patterns whilst examin-
ing for PAD.
Conclusion
The burden of Peripheral neuropathy and peripheral 
arterial disease is high and may go undetected if not 
screened for. We recommend that PAD and neuropathy 
be screened for in diabetic clinics.
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